Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial
by Press Release from Outbreak News Today on (#6B2E0)
Scientists at NIAID's Vaccine Research Center (VRC) report in two new studies that an experimental influenza vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial of volunteers. In fact, the vaccine has advanced to a second trial led by scientists at Duke University through NIAID's Collaborative [...]
The post Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial appeared first on Outbreak News Today.